ADDEX THERAPEUTICS LTD (ADXN)

US00654J2069 - ADR

7.79  +0.14 (+1.83%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
3.153M
-18.71%
1.445M
-54.18%
1.647M
13.99%
417.18K
-74.67%

-100.00%
6.908M
-100.00%
EBITDA
YoY % growth
-15.158M
-27.76%
-20.197M
-33.24%
-9.975M
50.61%
-5.149M
48.38%
-7.395M
-43.61%
-7.109M
3.86%
-5.822M
18.10%
-2.828M
51.42%
-2.828M-2.828M-2.828M
EBIT
YoY % growth
-15.506M
-26.65%
-20.52M
-32.34%
-10.281M
49.90%
-5.149M
49.91%
-7.436M
-44.40%
-7.13M
4.12%
-5.822M
18.34%
-2.828M
51.42%
-2.828M-2.828M-2.828M
Operating Margin
-491.73%-1,420.12%-624.22%-1,234.35%N/AN/A-84.28%N/AN/AN/AN/A
EPS
YoY % growth
N/A
19.08%
-9.54
76.95%
N/A
-33.79%
-6.66
47.79%
-6.19
7.04%
-5.11
17.42%
0.00
100.00%
-0.18-0.09
49.87%
0.04
150.00%
N/A

All data in CHF

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in CHF

Recent Earnings VS Estimates Surprises (CHF)
PeriodReportedEstimateDifferenceSurprise
Q4 2022
Q2Q % growth
-21.06
-576.34%
%
Recent Revenue VS Estimates Surprises (CHF)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
58.35K
-82.28%
%
Q2 2024
Q2Q % growth
115.28K
-81.76%
%
Q1 2024
Q2Q % growth
241.812K
-51.84%
%
Q4 2023
Q2Q % growth
183.83K
-81.88%
%
Q3 2023
Q2Q % growth
329.22K
-20.80%
%
Q2 2023
Q2Q % growth
631.98K
46.84%
%
Q1 2023
Q2Q % growth
502.05K
105.80%
%
Q4 2022
Q2Q % growth
1.015M
-12.46%
%
Q3 2022
Q2Q % growth
415.7K
-45.14%
%
Q2 2022
Q2Q % growth
430.39K
-78.42%
%
Q1 2022
Q2Q % growth
243.95K
-73.55%
%
Q4 2021
Q2Q % growth
1.159M
-41.89%
%
Q3 2021
Q2Q % growth
757.78K
638.22%
%
Q2 2021
Q2Q % growth
1.994M
5.81%
%
Q1 2021
Q2Q % growth
922.42K
-3.15%
%
Q4 2020
Q2Q % growth
1.994M
24.12%
%
Q2 2020
Q2Q % growth
1.885M
53.62%
%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% -0.79%
RevenueN/A N/A -65.92% -65.92%